Targeting B-Cell Malignancies With the Beta-Emitting Anti-Cd37 Radioimmunoconjugate 177Lu-Nnv003

European Journal of Nuclear Medicine and Molecular Imaging - Germany
doi 10.1007/s00259-019-04417-1